Generic placeholder image

Inflammation & Allergy - Drug Targets (Discontinued)

Editor-in-Chief

ISSN (Print): 1871-5281
ISSN (Online): 2212-4055

Intravenous Immunoglobulin Therapy in Dermatologic Disorders

Author(s): Seray Kulcu Cakmak, Ulker Gul, Muzeyyen Gonul, Arzu Kilic and Secil Soylu

Volume 7, Issue 2, 2008

Page: [75 - 84] Pages: 10

DOI: 10.2174/187152808785107651

Price: $65

Abstract

Intravenous immunoglobulin (IVIG) is sterilized and purified human plasma which contains supra-physiologic levels of immunoglobulin G. IVIG is currently used in the treatment of immunodeficiency syndromes, inflammatory disorders and infectious diseases. Although numerous immunomodulatory mechanisms have been suggested, the exact mechanisms of action are poorly understood. There is also accumulating evidence that high-dose IVIG is efficacious in the treatment of some skin diseases, despite the lack of evidence from randomized, double-blind, placebo-controlled trials. Though in most cases, IVIG is only effective in combination with other immunomodulating strategies, it offers new hope for the treatment of many severe dermatologic conditions. This article focuses on the efficacy and safety of IVIG therapy in skin diseases.

Keywords: Intravenous immunoglobulin, dermatology, skin diseases, side effects, indications


Rights & Permissions Print Export Cite as
┬ę 2024 Bentham Science Publishers | Privacy Policy